Physician profile
Jonathon E Borton
NPI 1548453681
$1,465.41
in general payments reported to CMS, 2019-2025
13 companies · $681 in 2025
The $681 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $179 · 2022: $224 · 2023: $158 · 2024: $223 · 2025: $681.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,062.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,062.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $443.55 | 2022-2025 | Airsupra |
| Amgen INC. | $221.41 | 2024-2025 | Repatha, Krystexxa, Otezla |
| Otsuka America Pharmaceutical, INC. | $180.09 | 2025 | Rexulti |
| Abbvie INC. | $167.22 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $146.07 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $101.27 | 2023 | Xifaxan |
| Medtronic, INC. | $55.82 | 2021 | |
| Novo Nordisk INC | $54.82 | 2021-2024 | Wegovy, Saxenda |
| Axsome Therapeutics, INC. | $34.87 | 2025 | Auvelity |
| Corium, LLC | $16.62 | 2024-2025 | Azstarys |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $16.05 | 2025 | Caplyta |
| Alkermes, INC. | $13.84 | 2022 | |
| Supernus Pharmaceuticals, INC. | $13.78 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathon Borton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.